Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2019

Planlagt Fastgjort Låst Flyttet Genmab
3.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • H Offline
    H Offline
    Hamming
    wrote on sidst redigeret af
    #1085

    Godt overblik

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #1086

      Suverænt link. Tak Hamming.

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #1087

        Mere om Revlimid http://www.gabionline.net/Generics/News/Alvogen-receives-European-approval-for-generic-lenalidomide

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1088

          Flere af disse patenter ser ud til at udløbe i 2020 https://www.drugs.com/availability/generic-revlimid.html

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1089

            Mystisk: The patents on Revlimid’s ‘last-to-expire’ key patents, according to C
            elgene, are only due to expire in the US in 2027 and in Europe in 2024.

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #1090

              Der kan være meget forskel på lande og verdensdele. Men det bliver et hullet tæppe som tiden går. Så vi ikke forleden "Doctor Reddys" der opgav - sikkert imod betaling fra CELG (Husker ikke navnet)

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #1091

                CELG har gjort alt for at forlænge patentet og tillige købt konkurrenter til at opgive eller udsætte launch.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #1092

                  Så nu bliver de nødt til at købe Genmab? 😉

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1093

                    Mike Thompson in good Dara mood today https://twitter.com/mtmdphd/status/1095658187859132416 https://twitter.com/mtmdphd/status/1095658194779676672

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      peter12
                      wrote on sidst redigeret af
                      #1094

                      Endnu mere om Revlimid http://www.taipeitimes.com/News/biz/archives/2017/09/09/2003678067

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #1095

                        Upon the expiration or loss of patent protection for a product, or upon the “at-risk” launch by a manufacturer of a generic version of one of our products, we can quickly lose a significant portion of our sales of that product. In addition, as additional competitors enter the market, our patented products may face increased competition or pricing pressure http://q4live.s22.clientfiles.s3-website-us-east-1.amazonaws.com/728481125/files/doc_financials/2018/b0b91209-0f73-447c-93ab-9027fb4c6bbf.pdf

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #1096

                          Celgene skriver en del om det i det
                          dokument, hvis man søger på "Our products may face competition"

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #1097

                            Ja,- Så der lidt at smide af i morgen hvis det går som det plejer. Men måske venter de til efter regnskab og guiding. 😉

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #1098

                              De danske banker sælger da i hvert fald ud i dag.

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                peter12
                                wrote on sidst redigeret af
                                #1099

                                Jeg læste et sted at generic Revlimid koster 1% af den originale ? Det må da også påvirke priserne i US, selvom det kun bliver markedsført i Europa ? https://www.npr.org/sections/health-shots/2018/05/17/571986468/how-a-drugmaker-gamed-the-system-to-keep-generic-competition-away?t=1550067479094

                                1 Reply Last reply
                                0
                                • JørgenVarnæsJ Offline
                                  JørgenVarnæsJ Offline
                                  JørgenVarnæs
                                  wrote on sidst redigeret af
                                  #1100

                                  Det skal sgu nok ændre dynamikken i markedet!!!

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    peter12
                                    wrote on sidst redigeret af
                                    #1101

                                    Og Celgene og BMS
                                    stiger på den nyhed 😉

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      pcf
                                      wrote on sidst redigeret af
                                      #1102

                                      https://finance.yahoo.com/news/johnson-johnson-buy-surgical-robotics-141605916.html

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #1103

                                        Revlimid US https://www.fiercepharma.com/pharma/days-after-revlimid-patent-win-u-s-generics-hit-european-markets

                                        1 Reply Last reply
                                        0
                                        • royalR Offline
                                          royalR Offline
                                          royal
                                          wrote on sidst redigeret af
                                          #1104

                                          😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger